Enanta Pharmaceuticals Aktie
13,50
EUR
+0,40
EUR
+3,05
%
16,86
USD
+0,26
USD
+1,57
%
Werbung
Enanta Pharmaceuticals Aktie Analyse
| 24.05.19 | Enanta Pharmaceuticals Outperform | Wolfe Research | |
| 21.11.17 | Enanta Pharmaceuticals Outperform | RBC Capital Markets | |
| 15.09.17 | Enanta Pharmaceuticals Outperform | RBC Capital Markets | |
| 06.04.15 | Enanta Pharmaceuticals Buy | Deutsche Bank AG |
Werbung
Werbung